Gerard D Schellenberg Selected Research

Cholesterol

1/2019	Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting.
1/2019	Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.
1/2019	Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.
9/2005	The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerard D Schellenberg Research Topics

Disease

63	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 01/2003
12	Frontotemporal Dementia (Semantic Dementia) 12/2014 - 08/2003
11	Dementia (Dementias) 01/2020 - 11/2002
8	Cognitive Dysfunction 09/2017 - 12/2005
7	Tauopathies 11/2021 - 12/2008
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 12/2005
6	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2021 - 01/2005
5	Autistic Disorder (Autism) 11/2014 - 04/2004
5	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2011 - 10/2007
5	Carotid Artery Diseases 03/2008 - 08/2003
4	Amyloid Plaque 01/2022 - 04/2011
4	Disease Progression 01/2020 - 01/2014
3	Corticobasal Degeneration 11/2019 - 01/2005
3	Inflammation (Inflammations) 01/2019 - 08/2006
3	Parkinson Disease (Parkinson's Disease) 08/2012 - 03/2008
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2008 - 12/2005
3	Vascular Diseases (Vascular Disease) 05/2006 - 08/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2005
2	Stroke (Strokes) 01/2019 - 12/2005
2	Infections 01/2014 - 06/2010
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2011 - 12/2005
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Genetic Risk Score 01/2021
1	Atrophy 08/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Amyloidosis 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Crohn Disease (Crohn's Disease) 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016
1	Neuroblastoma 07/2014
1	Intellectual Disability (Idiocy) 05/2014
1	Fragile X Syndrome (Martin Bell Syndrome) 05/2014

Drug/Important Bio-Agent (IBA)

38	Apolipoproteins E (ApoE)IBA 11/2022 - 09/2004
23	ApolipoproteinsIBA 11/2022 - 11/2002
13	Amyloid (Amyloid Fibrils)IBA 01/2022 - 08/2003
13	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
7	LipidsIBA 01/2021 - 03/2005
6	Amyloid beta-PeptidesIBA 10/2022 - 07/2006
6	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 12/2008
6	Biomarkers (Surrogate Marker)IBA 12/2018 - 07/2006
4	tau Proteins (tau Protein)IBA 01/2020 - 07/2013
4	CholesterolIBA 01/2019 - 09/2005
4	ProgranulinsIBA 04/2011 - 10/2007
3	Biological ProductsIBA 01/2022 - 02/2016
3	Carrier Proteins (Binding Protein)IBA 12/2019 - 10/2003
3	oxidized low density lipoproteinIBA 01/2019 - 03/2005
3	Vitamin E FDA LinkGeneric 01/2018 - 01/2014
3	Memantine (Namenda)FDA Link 01/2018 - 01/2014
3	DNA-Binding Proteins (DNA Binding Protein)IBA 04/2011 - 10/2007
3	UbiquitinIBA 05/2009 - 10/2007
3	Insulin (Novolin)FDA Link 01/2009 - 08/2003
3	Aryldialkylphosphatase (Paraoxonase)IBA 05/2006 - 08/2003
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2005
2	Apolipoprotein E4IBA 01/2020 - 06/2010
2	Leucine (L-Leucine)FDA Link 01/2018 - 05/2009
2	Alanine (L-Alanine)FDA Link 01/2018 - 02/2015
2	Phosphotransferases (Kinase)IBA 12/2017 - 05/2009
2	Peptides (Polypeptides)IBA 01/2017 - 05/2009
2	Threonine (L-Threonine)FDA Link 02/2015 - 04/2013
2	P-2 (P 2)IBA 05/2014 - 03/2010
2	alpha-Tocopherol FDA Link 01/2014 - 01/2014
2	AntioxidantsIBA 01/2014 - 09/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2010 - 12/2006
1	Complement C4 (Complement Component 4)IBA 11/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 11/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Tuberous Sclerosis Complex 1 ProteinIBA 11/2021
1	sharpinIBA 01/2021
1	Apolipoprotein E2IBA 01/2020
1	Messenger RNA (mRNA)IBA 12/2019
1	HDL LipoproteinsIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Amino Acids FDA Link 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018
1	Histidine (L-Histidine)FDA Link 01/2018
1	Isoleucine (L-Isoleucine)FDA Link 01/2018
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	Valine (L-Valine)FDA Link 01/2018
1	Peptide Initiation Factors (Initiation Factor)IBA 12/2017
1	Qa-SNARE Proteins (Syntaxin)IBA 12/2017
1	CaspasesIBA 01/2017
1	Caspase 8 (Caspase-8)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 06/2016
1	HLA-DRB5 Chains (HLA DRB5)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	C-Reactive ProteinIBA 06/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2014
1	Netrin ReceptorsIBA 12/2014
1	ChromatinIBA 11/2014
1	OligonucleotidesIBA 07/2014
1	N-Methylaspartate (NMDA)IBA 01/2014

Therapy/Procedure

2	Therapeutics 11/2021 - 07/2014
2	Activities of Daily Living (ADL) 01/2014 - 01/2014
1	Injections 01/2020